Key Takeaways
Here’s what we’ll cover:
Most people searching for weight loss shots near them have already heard the brand names, like Ozempic, Wegovy, or Zepbound. Maybe your doctor mentioned semaglutide, or a friend swears by tirzepatide. The question is usually not whether these medications work, but rather, the real question is which one is right for you and your unique needs, and where can you actually get it in Texas without going through a telehealth checkout form.
This article breaks down how GLP-1 weight loss injections work, compares semaglutide and tirzepatide side by side, and explains what InjectCo’s physician-guided weight loss program looks like for Texas patients who want in-person access to these medications.
InjectCo is a nurse-led medical aesthetics and wellness network with nine locations across Texas. Our weight loss programs are physician-guided, which means every patient receives a proper medical evaluation before any prescription is written.
GLP-1 stands for glucagon-like peptide-1. Your body naturally produces this hormone after you eat. It signals to your brain that you are full, slows the rate at which your stomach empties, and helps regulate blood sugar.
GLP-1 receptor agonists are injectable medications that mimic this natural hormone. When you take a GLP-1 injection, your body receives an amplified version of those satiety signals. The result is reduced appetite, slower digestion, and fewer cravings, particularly for high-calorie foods.
The two most commonly prescribed GLP-1 weight loss shots in Texas today are:
Both medications are once-weekly subcutaneous injections that require a prescription from a licensed medical provider. They are available through InjectCo’s physician-guided weight loss program across Texas.
The biggest clinical difference between these two medications comes down to receptor targeting. Semaglutide activates the GLP-1 receptor only, while tirzepatide activates both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor. This dual mechanism is why tirzepatide is sometimes called a ‘dual-action’ GLP-1.
For reference, here’s a side-by-side comparison of semaglutide and tirzepatide:
| Factor | Semaglutide (Wegovy / Ozempic) | Tirzepatide (Zepbound / Mounjaro) |
| Receptor target | GLP-1 only | GLP-1 + GIP (dual action) |
| FDA approval (weight loss) | Yes – Wegovy approved 2021 | Yes – Zepbound approved 2023 |
| Injection frequency | Once weekly | Once weekly |
| Starting dose | 0.25 mg per week, titrated up | 2.5 mg per week, titrated up |
| Clinical trial weight loss | Avg 15% body weight (STEP 1, 68 weeks) | Avg 20-22% body weight (SURMOUNT-1, 72 weeks) |
| Common side effects | Nausea, GI discomfort – mild in early weeks | Nausea, GI discomfort – similar profile |
| Available at InjectCo | Yes | Yes |
The SURMOUNT-1 trial published in the New England Journal of Medicine showed greater average weight loss with tirzepatide compared to the STEP 1 semaglutide trial results. That said, individual responses vary significantly. Starting BMI, health history, tolerance for side effects, and cost, all factor into which medication makes sense for a patient.
At InjectCo, our medical weight loss program in Fort Worth, TX, uses a physician-guided approach, which means that you are not choosing a medication based on a dropdown menu. Instead, you are evaluated by a licensed provider who can look at your full clinical picture.
These are prescription medications, not supplements, which means that understanding if you qualify before your consultation saves time and sets realistic expectations.
For your guidance, here’s a general eligibility criteria for GLP-1 weight loss shots:
Contraindications exist on both sides. Patients with certain thyroid conditions, those taking specific blood thinners, and those with active GI conditions may not be good candidates. A full medical evaluation by a licensed provider helps identify these risks.
| A patient we work with regularly, a woman in her late 30s from the Fort Worth area with a BMI just above 28 and newly diagnosed prediabetes, assumed she would not qualify based on her BMI alone. She did. Three weeks into semaglutide, she reported noticeably reduced appetite at dinner. What we told her was the same thing we tell every patient: eligibility is a medical determination, not something you figure out from a comparison article. |
If you are unsure whether you qualify for a semaglutide weight loss program near Fort Worth, the right next step is a free consultation with a real clinical team.
InjectCo is not a telehealth-only operation. Our weight loss programs run through in-person clinical settings across our nine Texas locations, with consistent physician oversight throughout the process.
Here’s a step-by-step guide of what to expect from our physician-guided weight loss program in Texas:
InjectCo Fort Worth
4701 West Fwy Suite 152, Fort Worth TX 76107
Inside Chapel Hill Shopping Center (same center as Central Market and World Market). Approximately 2 miles north of TCU campus. Easily accessible from I-30 westbound.
Call or text: (817) 285-5254
5964 W Parker Rd Suite 107, Plano TX 75093
Inside Phenix Suites of Willow Bend.
Call or text: (972) 430-9297
| Ready to find out if GLP-1 weight loss shots are right for you?InjectCo offers free 15-minute virtual consultations at all nine Texas locations. No commitment needed. A real nurse and physician team will review your case directly. Book Your Free Consultation Or text: (817) 285-5254 (Fort Worth) | (972) 430-9297 (Plano) |
If you are searching for weight loss shots near you in Texas, here’s what to look for and what to avoid.
Here’s what a legitimate provider, like InjectCo, looks like:
And here’s what to watch out for:
Compounded semaglutide and tirzepatide are legal to prescribe in Texas through licensed compounding pharmacies. The FDA has published specific guidance on unapproved GLP-1 drugs circulating online, and knowing this important distinction protects both your health and your investment.
For more on what the week-by-week dosing process looks like, the semaglutide dosage chart for weight loss we use at InjectCo breaks down the full titration schedule from starting dose through maintenance.
GLP-1 weight loss shots, whether semaglutide or tirzepatide, are among the most effective physician-guided options available for patients who have struggled with weight through diet and exercise alone. If you are in Texas and ready to find out which option fits your profile, InjectCo’s free virtual consultation is the fastest way to get an honest answer from a real clinical team.
A: Ozempic contains semaglutide and is FDA-approved for type 2 diabetes. Wegovy is the same active ingredient but approved specifically for chronic weight management. Tirzepatide, found in Zepbound and Mounjaro, is a different molecule that targets both GLP-1 and GIP receptors. Not all weight loss shots are the same, and the right choice depends on your health history and how your body responds.
A: Yes. Both semaglutide and tirzepatide are prescription medications. Any provider offering these without a full medical evaluation and prescription is operating outside legal and safety standards. InjectCo requires a complete medical evaluation before any prescription is issued.
A: Pricing depends on the medication and your dosing schedule. InjectCo’s compounded semaglutide program starts at $249 per month. Tirzepatide programs are priced separately based on dose. Your consultation will include a full pricing breakdown specific to your program.
A: Brand-name semaglutide (Wegovy, Ozempic) and compounded semaglutide contain the same active ingredient but are produced through different channels. Compounded versions are prepared by licensed compounding pharmacies and are typically more affordable. InjectCo uses compounded semaglutide from licensed pharmacies operating in compliance with Texas state regulations.
A: Most patients notice reduced appetite within two to three weeks of starting. Visible weight changes typically begin around weeks four to six, though timelines vary by individual. Clinical trial data shows average weight reductions of 15% with semaglutide and 20-22% with tirzepatide over 68 to 72 weeks. These are clinical averages, not guarantees. Individual results depend on diet, activity level, and consistency of treatment.
A: Yes. InjectCo’s Fort Worth clinic at 4701 West Fwy Suite 152 serves patients from Benbrook, White Settlement, Lake Worth, North Richland Hills, Saginaw, and surrounding communities. The clinic is inside Chapel Hill Shopping Center, about two miles north of the TCU campus, and is easily accessible from I-30 westbound.
A: Clinical trial data from the SURMOUNT-1 study showed higher average weight loss with tirzepatide compared to semaglutide’s STEP 1 results. However, both medications produce meaningful outcomes, and individual responses vary. The right medication for you depends on your full health picture, not a general ranking. A provider who evaluates you directly is the right person to make that call.
Written by: Kiara DeWitt, BSN, RN, CPN
Kiara DeWitt, BSN, RN, CPN is the founder of InjectCo MedSpa and a former lead clinical educator in the neurosurgery and neurology unit at Cook Children’s Pediatric Hospital. She earned her nursing degree from Texas Christian University and has performed thousands of aesthetic treatments across InjectCo’s 9 Texas locations. She founded the Texas Academy of Medical Aesthetics to raise the standard of nurse-led aesthetic care statewide.
| The information in this article is for educational purposes only and does not constitute medical advice. Results vary by individual. Always consult a licensed healthcare provider before beginning any medical treatment or aesthetic procedure. |
